Pearl River Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,440
Closed -$354K 621
2024
Q1
$354K Buy
23,440
+876
+4% +$15.9K 0.06% 359
2023
Q4
$486K Sell
22,564
-24,613
-52% -$454K 0.08% 319
2023
Q3
$877K Sell
47,177
-16,516
-26% -$386K 0.14% 244
2023
Q2
$1.61M Buy
63,693
+16,055
+34% +$404K 0.26% 126
2023
Q1
$1.23M Buy
47,638
+5,496
+13% +$147K 0.2% 157
2022
Q4
$997K Buy
42,142
+3,884
+10% +$105K 0.17% 194
2022
Q3
$970K Buy
38,258
+15,764
+70% +$553K 0.18% 175
2022
Q2
$747K Buy
+22,494
New +$955K 0.18% 186
2022
Q1
Sell
-2,557
Closed -$235K 553
2021
Q4
$235K Buy
+2,557
New +$306K 0.06% 346
2021
Q3
Sell
-6,815
Closed -$1.13M 546
2021
Q2
$1.13M Buy
+6,815
New +$1.1M 0.31% 107
2020
Q4
Sell
-3,310
Closed -$726K 499
2020
Q3
$726K Buy
+3,310
New +$701K 0.31% 107
2019
Q3
Sell
-2
Closed 526
2019
Q2
$0 Sell
2
-4,364
-100% -$254K ﹤0.01% 461
2019
Q1
$242K Buy
4,366
+4,225
+2,996% +$258K 0.6% 46
2018
Q4
$7K Buy
+141
New +$8.63K 0.03% 652

Other funds holding TDOC

Pearl River Capital's TDOC Position: Q2 2024 in Review

Pearl River Capital sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 23,440 shares — an estimated $354K sold.

Pearl River Capital first reported a position in TDOC in Q4 2018 and held it in 14 quarters. The position peaked at $1.61M in Q2 2023. 405 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Pearl River Capital reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Pearl River Capital sold 23,440 Teladoc Health shares in Q2 2024, an estimated $354K.
  • Pearl River Capital first reported a position in Teladoc Health in Q4 2018 and held it in 14 quarters.
  • Pearl River Capital's Teladoc Health position peaked at $1.61M in Q2 2023.
  • 405 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Pearl River Capital's 13F filing for Q2 2024, filed 13 Aug 2024.